Tài liệu tham khảo của A.5 được tổ chức theo sáu nhóm chủ đề tương ứng với sáu nhóm thuật ngữ. Số trong ngoặc vuông được dùng nhất quán trong toàn bộ bộ 36 tài liệu của bộ hồ sơ. Nhóm 1 gồm guideline gút và các đích kiểm chứng; Nhóm 2 gồm integrated care và multimorbidity; Nhóm 3 gồm guideline xét nghiệm và ngưỡng sinh học; Nhóm 4 gồm phương tiện hình ảnh và chuẩn quốc tế; Nhóm 5 gồm khoa học triển khai và khung guideline; Nhóm 6 gồm các tài liệu về vận hành và quản trị. Toàn bộ danh mục tham khảo chuẩn của A.5 được giữ đúng theo bản gốc.

• [1] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744–760.
• [2] Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42.
• [3] Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Ann Rheum Dis. 2006;65(10):1312–1324.
• [4] Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout Classification Criteria: an ACR/EULAR collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798.
• [5] Pascual E, Sivera F, Andres M. Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011;23(2):161–169.
• [6] World Health Organization. Framework on Integrated, People-centred Health Services. Geneva: WHO; 2016.
• [7] Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care. Lancet. 2012;380(9836):37–43.
• [8] Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20(6):64–78.
• [9] World Health Organization. Integrated Care for Older People (ICOPE). Geneva: WHO; 2019.
• [10] Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–2874.
• [11] Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.
• [12] Pham HH, Schrag D, O’Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007;356(11):1130–1139.
• [13] World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013–2030. Geneva: WHO; 2023.
• [14] KDIGO CKD Work Group. KDIGO 2024 Clinical Practice Guideline for CKD. Kidney Int. 2024;105(4S):S117–S314.
• [15] McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
• [16] European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines for decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
• [17] Caraceni P, Tonon M, Vizzutti F, et al. Definition and diagnosis of refractory ascites in cirrhosis. Dig Liver Dis. 2019;51(5):611–615.
• [18] Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749.
• [19] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2018;72(18):2231–2264.
• [20] Gutierrez M, Schmidt WA, Thiele RG, et al. International Consensus for ultrasound lesions in gout. Rheumatology. 2015;54(10):1797–1805.
• [21] Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout. Ann Rheum Dis. 2015;74(6):1072–1077.
• [22] Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in NAFLD: a comparison of SSI, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817–1827.
• [23] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. J Am Soc Echocardiogr. 2015;28(1):1–39.
• [24] Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines on Clinical Use of Liver Ultrasound Elastography. Ultraschall Med. 2017;38(4):377–394.
• [25] Eccles MP, Mittman BS. Welcome to Implementation Science. Implement Sci. 2006;1:1.
• [26] Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change. Lancet. 2003;362(9391):1225–1230.
• [27] Graham ID, Logan J, Harrison MB, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26(1):13–24.
• [28] World Health Organization. Knowledge translation for public health. Geneva: WHO; 2004.
• [29] Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence. BMJ. 2008;336(7650):924–926.
• [30] Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–72.
• [31] Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ. 2008;337:a1714.
• [32] Coleman EA. Falling through the cracks: challenges for improving transitional care for persons with complex care needs. J Am Geriatr Soc. 2003;51(4):549–555.
• [33] Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–1539.
• [34] Deane KD, O’Donnell CI, Hueber W, et al. The number of elevated cytokines in preclinical seropositive RA predicts time to diagnosis. Arthritis Rheum. 2010;62(11):3161–3172.
• [35] Institute of Medicine (IOM). Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington DC: National Academies Press; 2013.